Showing results (441-450 of 517) with videos related to

Sort By:
Pageof 52
Plos Pathogens|May 27, 2020
Irgm1-deficiency leads to myeloid dysfunction in colon lamina propria and susceptibility to the intestinal pathogen Citrobacter rodentiumGregory A Taylor, Hsin-I Huang, Brian E Fee, et al.
The American Journal of Medicine|January 12, 2008
Acupuncture versus sham acupuncture for chronic prostatitis/chronic pelvic painShaun Wen Huey Lee, Men Long Liong, Kah Hay Yuen, et al.
The Journal of Urology|March 11, 2005
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled studyJ Curtis Nickel, John B Forrest, Kevin Tomera, et al.
Cancer|December 11, 2012
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrenceAllen S Ho, Gabriel J Tsao, Frank W Chen, et al.
American Journal of Epidemiology|September 18, 1999
Risk factors for HIV-1 shedding in semenC E Speck, R W Coombs, L A Koutsky, et al.
The Journal of Urology|April 5, 2017
Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network StudyH Henry Lai, Thomas Jemielita, Siobhan Sutcliffe, et al.
The Journal of Biological Chemistry|October 12, 2024
Type I interferon signaling and peroxisomal dysfunction contribute to enhanced inflammatory cytokine production in IRGM1-deficient macrophagesBrian E Fee, Lanette R Fee, Mark Menechella, et al.
BJU International|December 2, 2025
Urologic chronic pelvic pain syndrome 3-year symptom trajectories: the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Symptom Patterns StudyCatherine S Bradley, Mengying You, Wensheng Guo, et al.
The Journal of Urology|January 21, 2022
Reliability and Validity of Pain and Urinary Symptom Severity Assessment in Urological Chronic Pelvic Pain: A MAPP Network AnalysisBruce D Naliboff, Kenneth Locke, Andrew D Schrepf, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
Pageof 52